Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

962
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
962
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

787
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
787
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis-infected macaques.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Genetically diverse CC and DO mouse models enable comprehensive assessments of novel tuberculosis vaccines.

NPJ vaccines·2026
Same author

Smooth-to-rough morphotype alterations in <i>Mycobacterium abscessus</i> and their putative impact on phage resistance.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

An ESAT-6-convergent prime-boost vaccination combining recombinant BCG expressing Mycobacterium marinum ESX-1 and ESAT-6/GLA-SE improves TB protection.

NPJ vaccines·2026
Same author

Improved immune responses and tuberculosis protection by aerosol vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum.

PLoS pathogens·2026
Same author

Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1<sup>+</sup> cDC1 infiltration and activates anti-tumor immunity.

Nature communications·2025

Related Experiment Video

Updated: Apr 22, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K

Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.

Fabien Le Chevalier1, Alessandro Cascioferro, Laleh Majlessi

  • 1Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.

Future Microbiology
|October 11, 2014
PubMed
Summary

Mycobacterium tuberculosis causes complex human TB disease. Recent studies reveal pathogen evolution and new drug targets essential for growth, aiding anti-TB treatment development.

Keywords:
Mycobacterium tuberculosisattenuationdrug developmentevolutionsecretion systemsvirulence factors

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

Related Experiment Videos

Last Updated: Apr 22, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

Area of Science:

  • Microbiology
  • Evolutionary Biology
  • Infectious Diseases

Background:

  • Mycobacterium tuberculosis is the primary cause of human tuberculosis (TB), a severe global health issue.
  • The pathogen's complex disease mechanisms stem from host-pathogen coevolution, potentially originating from Mycobacterium canettii-like ancestors.
  • Despite advances, M. tuberculosis's strategies for evading host defenses, persisting, and developing drug resistance remain incompletely understood, leading to lengthy and often ineffective treatments.

Purpose of the Study:

  • To review recent findings on the evolutionary trajectory of Mycobacterium tuberculosis.
  • To identify and discuss potential new drug targets crucial for mycobacterial survival and growth.
  • To enhance understanding of M. tuberculosis pathogenesis and inform the development of improved anti-TB therapies.

Main Methods:

  • Literature review of recent studies on Mycobacterium tuberculosis evolution.
  • Analysis of research on host-pathogen interactions and resistance mechanisms.
  • Identification of essential genes and pathways for mycobacterial growth in vitro and in vivo.

Main Results:

  • Insights into the evolutionary history of M. tuberculosis and its relationship with progenitor strains.
  • Identification of several putative drug targets critical for M. tuberculosis viability.
  • Understanding of mechanisms underlying pathogen persistence and drug resistance development.

Conclusions:

  • Continued research into M. tuberculosis evolution is vital for uncovering novel therapeutic strategies.
  • Targeting essential growth pathways presents a promising avenue for developing new anti-TB drugs.
  • Addressing M. tuberculosis's complex survival strategies is key to overcoming treatment challenges.